Accessibility Menu
Claritev logo

Claritev(NYSE) CTEV

Market Cap$414.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-94%
5 Year-92%
1 Year-37%
1 Month-26%
$24.72
+8.85%
+2.01Today
After hours$24.28-$0.44 (-1.78%)
Claritev last closing stock price
MetricPriceDate
Last closeUSD 24.292026-08-03
Claritev stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+11.32%USD 21.822026-07-27
1 month-25.58%USD 32.642026-07-02
3 month-7.89%USD 26.372026-05-05
Year to date-43.18%USD 42.752025-12-31
1 year-36.88%USD 38.482025-08-01
3 year-66.08%USD 71.602023-08-04
5 year-92.13%USD 308.802021-08-04
Since inception-94.16%USD 388.802020-04-03

Claritev Financials at a Glance

Market Cap

$414.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$978.76M

Net Income (TTM)

-$286.52M

EPS (TTM)

-$17.32

P/E Ratio

-1.40

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$24.72

Volume

55,919

Open

$22.91

Previous Close

$24.29

Daily Range

$22.91 - $24.83

52-Week Range

$11.50 - $74.07

Estimated Earnings Date

Aug 7, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Claritev

MultiPlan Corporation is a leading provider of data analytics and technology-enabled solutions in the U.S. healthcare industry. The company focuses on reducing costs, increasing efficiency, and ensuring fairness in healthcare through its comprehensive platform. MultiPlan primarily services healthcare payors, including insurers and self-insured employers, helping them manage healthcare expenses and billing accuracy.

Products and Services

Analytics-Based Services: Detect claims overcharges and recommend fair reimbursements using data-driven algorithms.

Network-Based Services: Contracted discounts with healthcare providers to form large independent PPO networks.

Payment and Revenue Integrity Services: Identify and remove improper charges, and restore and preserve premium dollars.

Data and Decision Science Services: Apply advanced analytics to support decision-making and plan performance.

What Makes MultiPlan Corporation Special

MultiPlan is distinguished by its proprietary data and technology platform, which is deeply integrated with customers' IT environments. This integration allows for efficient pre-payment claim processing, reducing unnecessary healthcare costs and increasing payment accuracy. The company's strong relationships with over 700 payors and its extensive provider network further enhance its competitive position.

Five Things You Need to Know

Over 60 million consumers have access to MultiPlan services through various health plans.

MultiPlan has identified $22.9 billion in potential savings on $168.6 billion in claims for 2023.

The company has relationships with over 1.4 million healthcare providers across the U.S.

MultiPlan was founded in 1980 and became a publicly traded company in 2020.

Three customers account for a significant portion of MultiPlan’s revenue: 25%, 22%, and 8% respectively in 2023.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Employees

3,000

CEO

Travis S. Dalton

Headquarters

McLean, VA 22102, US

CTEV Financials

Key Financial Metrics (TTM)

Gross Margin

61.06%

Operating Margin

4.29%

Net Income Margin

-29.27%

Return on Equity

205.84%

Return on Capital

1.01%

Return on Assets

-5.92%

Earnings Yield

-71.43%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$414.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

17.05M

Volume

55.92K

Avg. Volume

149.11K

Financials (TTM)

Gross Profit

$597.67M

Operating Income

$41.99M

EBITDA

$517.45M

Operating Cash Flow

$101.60M

Capital Expenditure

-$137.50M

Free Cash Flow

-$35.90M

Cash & ST Invst.

$21.33M

Total Debt

$4.61B

Claritev Performance Analysis

Claritev annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,079,716,000-3.4%
20232023-12-31USD 961,524,000-10.9%
20242024-12-31USD 930,624,000-3.2%
20252025-12-31USD 965,413,0003.7%
Claritev sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-304.4%
Q32025-09-301.8%
Q42025-12-310.2%
Q12026-03-31-0.8%
Claritev annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -35.87N/A
20232023-12-31USD -5.69-84.1%
20242024-12-31USD -101.921692.7%
20252025-12-31USD -17.30-83.0%
Claritev sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3013.0%
Q32025-09-30-11.0%
Q42025-12-31-15.4%
Q12026-03-319.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$244.68M

+5.8%

Gross Profit

$64.51M

-62.3%

Gross Margin

26.36%

N/A

Market Cap

$414.09MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$138.03K

N/A

Employees

3,000

N/A

Net Income

-$73.56M

-3.1%

EBITDA

$116.82M

+3.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$21.33M

-7.8%

Total Debt

$4.61B

-0.5%

Accounts Receivable

$154.22M

+32.3%

Inventory

$0.00

N/A

Long Term Debt

$4.59B

-0.5%

Short Term Debt

$19.60M

+1.6%

Return on Assets

-5.92%

N/A

Return on Invested Capital

0.90%

N/A

Free Cash Flow

-$92.55M

-34.3%

Operating Cash Flow

-$45.78M

-52.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVHEvolent Health, Inc.
$3.14+1.62%
LFMDLifeMD, Inc.
$3.73+6.57%
INMDInMode Ltd.
$15.35+1.39%
SANASana Biotechnology, Inc.
$3.18+1.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$23.99+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$67.96+0.05%
PLTRPalantir Technologies
$125.65+0.02%
INTCIntel
$91.00+0.01%

Questions About CTEV

What is the current price of Claritev?

Claritev is trading at $24.29 per share.

What is the 52-week range for Claritev?

Over the past 52 weeks, Claritev has traded between $11.50 and $74.07.

How much debt does Claritev have?

As of the most recent reporting period, Claritev reported total debt of $4.73B.

How much cash does Claritev have on hand?

Claritev reported $34.73M in cash and cash equivalents in its most recent financial results.

What is Claritev’s dividend yield?

Claritev does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.